Chris Corbin announces intention to retire from Ashfield in April 2019

In preparation for his retirement, Chris will transition to the role of Chairman of Ashfield in spring 2017 once his successor has been appointed. This will facilitate a phased transition of Chris’s responsibilities over the next two and half years. In addition, Chris will remain as a member of the Board of Directors of UDG Healthcare until his retirement.
Chris Corbin, CEO of Ashfield and Board Member of UDG Healthcare, said: “From the foundation of our business to the present day I have had the great pleasure and honour of working with many wonderful and talented people in our organisation, and I would like to thank you all for the unstinting support you have given me throughout the years as we have grown Ashfield, from the humblest of beginnings, to a truly international company, operating in over 20 countries and employing over 6,000 people.”
Brendan McAtamney, CEO of UDG Healthcare, said: “I would like to thank Chris for his substantial contribution to the success of both the Group and Ashfield since joining us in 2000. Under his leadership, Ashfield has developed into a leading international healthcare services organisation and a key division of the Group. We will work closely with Chris over the next two and a half years to ensure a professional transition process and thereafter wish him the very best in retirement”.
For media enquiries, please contact Lucy MacLauchlan, Divisional Head of Marketing on [phone].
The post Chris Corbin announces intention ...

Source: Ashfield Healthcare News - September 26, 2016 Category: Pharmaceuticals Authors: Olaf Spinkel Tags: Ashfield Source Type: news